However, the role of PAK1 in PD-L1 control has been shown more convincingly in pancreatic cancer models, where the loss of PAK1 decreased PD-L1 expression while increasing tumor infiltration by CD4+ and CD8+ T-cells [137]. This evidence concerns the gene PAK1 and familial pancreatic carcinoma.